3-(4-(5-amino-1,3,4-thiadiazol-2-yl)phenyl)-N-(4-cyanophenyl)-N-methylimidazo[1,2-a]pyrazine-6-carboxamide

ID: ALA3325605

Chembl Id: CHEMBL3325605

PubChem CID: 90157733

Max Phase: Preclinical

Molecular Formula: C23H16N8OS

Molecular Weight: 452.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C(=O)c1cn2c(-c3ccc(-c4nnc(N)s4)cc3)cnc2cn1)c1ccc(C#N)cc1

Standard InChI:  InChI=1S/C23H16N8OS/c1-30(17-8-2-14(10-24)3-9-17)22(32)18-13-31-19(11-27-20(31)12-26-18)15-4-6-16(7-5-15)21-28-29-23(25)33-21/h2-9,11-13H,1H3,(H2,25,29)

Standard InChI Key:  KHDKYBZVFJSCMX-UHFFFAOYSA-N

Associated Targets(non-human)

Plasmodium cynomolgi (553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium yoelii (6656 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.50Molecular Weight (Monoisotopic): 452.1168AlogP: 3.65#Rotatable Bonds: 4
Polar Surface Area: 126.09Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.50CX LogP: 1.96CX LogD: 1.96
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.86

References

1. Zou B, Nagle A, Chatterjee AK, Leong SY, Tan LJ, Sim WL, Mishra P, Guntapalli P, Tully DC, Lakshminarayana SB, Lim CS, Tan YC, Abas SN, Bodenreider C, Kuhen KL, Gagaring K, Borboa R, Chang J, Li C, Hollenbeck T, Tuntland T, Zeeman AM, Kocken CH, McNamara C, Kato N, Winzeler EA, Yeung BK, Diagana TT, Smith PW, Roland J..  (2014)  Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.,  (8): [PMID:25147620] [10.1021/ml500244m]

Source